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Structure–function of cyclic peptideWe report the molecular basis for the differences in activity of cyclic and linear antimicrobial peptides. We
iteratively performed atomistic molecular dynamics simulations and biophysical measurements to probe the
interaction of a cyclic antimicrobial peptide and its inactive linear analogue with model membranes. We
establish that, relative to the linear peptide, the cyclic one binds stronger to negatively charged membranes.
We show that only the cyclic peptide folds at the membrane interface and adopts a β-sheet structure
characterised by two turns. Subsequently, the cyclic peptide penetrates deeper into the bilayer while the
linear peptide remains essentially at the surface. Finally, based on our comparative study, we propose a model
characterising the mode of action of cyclic antimicrobial peptides. The results provide a chemical rationale for
enhanced activity in certain cyclic antimicrobial peptides and can be used as a guideline for design of novel
antimicrobial peptides.Sciences and Biotechnology
dvanced Materials. Proteomics
ls, University of Groningen,
31 50 3634165.
l rights reserved.© 2011 Elsevier B.V. All rights reserved.1. Introduction
Antimicrobial peptides (AMPs) are currently in the spotlight as
potential candidates to overcome bacterial resistance to conventional
antibiotics. These peptides are natural weapons produced by a variety
of organisms, including insects, animals and plants [1,2]. While
displaying a wide spread in primary structures, most antimicrobial
peptides exhibit common basic features [3–5]. The linear α-helical
peptides have been shown to be unstructured in water and adopt a
secondary structure upon association with the membrane [6,7].
Although acquiring structure uponmembrane binding is an important
feature of these AMPs, short peptides lacking a well-deﬁned
secondary structure are also active [8]. Cyclic AMPs are amongst the
most effective antimicrobial agents [9,10] and some members of the
family have been shown to adopt a structure even in water [11]. One
of the best studied examples is gramicidin S, whose structure in
aqueous media, an anti-parallel β-sheet characterised by two turns, isimportant for its activity [12]. Comparative studies between related
peptides with differing activities, although not yet been undertaken,
would help us rationalise the essential structural properties vital for
function and will help us design more potent antimicrobial peptides.
Besides acquiring structure at the membrane interface, the parti-
tioning behaviour of the peptides, i.e. the membrane-aqueous medium
partition coefﬁcient and the membrane penetration depth also
contribute to their efﬁcacy and action and selectivity [13]. In fact, the
local concentrationsof AMPs in themembrane canbeup to10,000 times
higher than in the aqueous phase [14]; therefore the understanding of
partitioningbehaviour is of importance tounravelmechanismsof action
of these peptides. Again, undertaking comparative studies would help
us distinguish between essential and non-essential differences in
partitioning and help to extract only the critical features.
The focus of our work is a cyclic peptide, BPC194 [c(KKLKKFKKLQ)],
which, from a library of de novo designed cyclic decapeptides, proved
most active against plant pathogens such as Erwinia amylovora,
Pseudomonas syringae and Xanthomonas vesicatoria [15,16]; its linear
analogue is poorly active. Here, we present a combined Molecular
Dynamics (MD) and biophysical study of the cyclic peptide interacting
with anionic lipid bilayers to understand its mechanism of action. The
linear analogue, BPC193 has been studied to contrast the behaviour of
the two related peptides and extract the molecular basis for antimicro-
bial activity. We show how the cyclic and linear peptides differ both in
2198 J.T. Mika et al. / Biochimica et Biophysica Acta 1808 (2011) 2197–2205their partitioning behaviour and their folding state upon interaction
with membranes. We speculate that these differences are related to
differences in pore forming activity.
2. Materials and methods
2.1. Biophysical characterisation
2.1.1. Materials
The 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES)
and 2-amino-2-(hydroxymethyl)-1,3-propanediol (Tris–HCl) were
from Roche Diagnostics GmbH (Germany), sodium chloride, sodium
ﬂuoride and Triton-X100 were fromMerck (Germany). Phospholipids
1,2-dioleoyl-sn-glycero-3-phosphatidylcholine (DOPC), 1,2-dioleoyl-
sn-glycero-3-phosphatidylglycerol (DOPG) and 1,2-dioleoyl-sn-
glycero-3-phosphatidyl-ethanolamine (DOPE) were from Avanti
Polar Lipids.
2.1.2. Peptide synthesis
Decapeptides investigated in this study (Table 1) varied in the type
of aromatic amino acid at position 6 and included cyclic analogues:
BPC194, BPC294 and BPC418, together with their linear counterparts,
BPC193, BPC293 and BPC417. All of them were synthesised by solid
phase peptide synthesis as described in Supplementary Data (1.
Materials and Methods).
2.1.3. Liposome preparation
2.1.3.1. Liposomes for calcein dequenching. Liposomes were prepared
as described previously [17]. Brieﬂy, liposomes at a ﬁnal concentration
of 1 mM of lipid molecules were prepared by rehydration of a dried
lipid ﬁlm with 100 mM calcein-NaOH in 10 mM HEPES, pH 7.0. The
vesicles were then subjected to ﬁve cycles of ﬂash freezing in liquid
nitrogen and rapid thawing at 50 °C. Subsequently, the liposomes
were sonicated (5×10 s pulses at 75% amplitude with a Sonics Vibra
Cell VCX 130 sonicator) to obtain unilamellar vesicles. Liposomes
were separated from the non-encapsulated dye by size exclusion
chromatography (Sephadex G-75, GE Healthcare). The column was
equilibrated and eluted with 10 mM HEPES, pH 7.0, plus 150 mM
NaCl, further refered as buffer A.
2.1.3.2. Liposomes for circular dichroism (CD). Liposomes were
prepared similarly as described for the calcein dequenching experi-
ments except that the dried lipid ﬁlm was rehydrated with 10 mM
sodium phosphate, pH 7.0, plus 150 mM NaF to a ﬁnal concentration
of 25 mM lipids. Sodium chloride was replaced by sodium ﬂuoride to
reduce the noise levels at wavelengths b200 nm, which is caused by
chloride ions. Furthermore, liposomes were extruded through a
30 nm polycarbonate ﬁlter (Whatman International Ltd, UK), instead
of sonication, to obtain a more homogenous sample.
2.1.3.3. Liposomes for binding and tryptophan environment assays.
Liposomes were prepared by rehydration of DOPG phospholipid ﬁlms
in buffer A to a ﬁnal concentration of 25 mM and subsequently
extruded through a 200 nm polycarbonate ﬁlter.Table 1
Names and sequences of the peptides used in this study.
Cyclic Linear
Code Sequence Code Sequence
BPC194 c(KKLKKFKKLQ) BPC193 H-KKLKKFKKLQ-OH
BPC294 c(KKLKKYKKLQ) BPC293 H-KKLKKYKKLQ-OH
BPC418 c(KKLKKWKKLQ) BPC417 H-KKLKKWKKLQ-OH2.1.4. Calcein dequenching
The calcein dequenching assay was performed as reported
previously [17]. A 20 μl sample of liposomes (1 mM of lipid), obtained
as described in Section 2.1.3.1 of Materials andmethods, was placed in
3 ml of buffer A, which yielded a ﬁnal concentration of 6.7 μM of lipid
in the cuvette. The membrane permeabilizing activity of the peptide
was followed by measuring the increase in ﬂuorescence (calcein
dequenching), resulting from vesicle leakage after peptide addition
(0–52 μM). Fluorescence emission was monitored at 520±5 nm
(excitation at 485±2 nm) in a Cary Eclipse Fluorescence Spectro-
photometer (Varian Inc.). The release of the calcein was calculated as
a percentage of the total amount present in the liposomes:
% Release = I−I0ð Þ= I100−I0ð Þ × 100;
where I is themeasured ﬂuorescence intensity at a given time, I0 is the
initial background ﬂuorescence intensity and I100 is the ﬂuorescence
intensity upon complete lysis of the liposomes, which was elicited by
adding Triton X-100 (0.06% ﬁnal concentration).
2.1.5. Circular dichroism
Far-UV circular dichroism spectrawere recorded on a Jasco J-815 CD
spectrometer (Jasco, UK) between 190 and 250 nm at room tempera-
ture and scanning every 1 nm, using a quartz cell of 1 mm path length.
The peptide at 0.15 mMwas titrated with small aliquots (1 to 10 μl) of
DOPG liposomes at a concentration of 25 mM. 2,2,2-Triﬂuoroethanol
(TFE, Janssen Chimica) was used as a secondary structure inducer. The
spectra were corrected for the absorption of buffer and vesicles.
2.1.6. Peptide environment probed with tryptophan ﬂuorescence
The tryptophan analogues (BPC417 and BPC418) were placed in a
quartz cuvette in buffer A at 2 μMand their ﬂuorescencewasmonitored
with a Fluorlog-3 (Jobin Yvon) spectroﬂuorimeter at an excitation
wavelength of 285±5 nm and emission scanning from 295 to 400 nm.
Different amounts of DOPGvesicleswere introduced into the cuvette (at
ﬁnal lipid concentrations of 2.28, 28 and 275 μM, corresponding to P:L
ratios of 0.88, 0.071 and 0.0073, respectively). Subsequently, NaCl was
titrated into the cuvette to a ﬁnal concentration of 350 mM. The
emission spectra were corrected with the corresponding buffer spectra
(including DOPG and salt) and ﬁtted to a skewed Gaussian curve [18] to
obtain the ﬂuorescence emission maximum, λmax.
2.1.7. Peptide binding by ultracentrifugation
Increasing amounts of DOPG liposomes (0–753 μM)were added to
0.5 ml of 6 μM peptide in buffer A up to a P:L ratio of 1:114 and
incubated for 20 min at room temperature. The samples were spun
down by ultracentrifugation (1 h at 270,000g) and supernatants were
separated from the pellets. A control experiment with an encapsu-
lated dye in the same vesicles was carried out and under those
conditions the vesicles were quantitatively spun down. To correct for
the differences in quantum yield of the tryptophan ﬂuorescence in
different environments (hydrophilic buffer A vs. hydrophobic mem-
brane environment), 2% (w/v) of sodium dodecyl sulphate (SDS) was
added to the supernatant fraction and the ﬂuorescence wasmeasured.
A correction was made for the background signal using a reference
solution of buffer A, liposomes and SDS without the peptide. The
percentage of binding was calculated using the equation:
% Binding = 100− I0 = I × 100ð Þ;
where, I0 is the ﬂuorescence intensity of the supernatant sample with
peptide without liposomes and I is the ﬂuorescence intensity of the
samples with liposomes. The obtained data were ﬁtted to a general
binding equation to obtain the dissociation constant (Kd):
% Binding = Bmax × Clipid
 
= Kd + Clipid
 
;
Fig. 1. Vesicle permeabilizing properties of peptides. Leakage of calcein as a function of
peptide concentration is shown. A. Circles: the action of BPC194 on DOPG and DOPC
vesicles (ﬁlled and hollow symbols, respectively). Squares: data obtained with BPC193
with DOPG and DOPC vesicles (small ﬁlled and big hollow symbols, respectively).
B. Calcein dequenching results for BPC194 using liposomes of different lipid composition:
DOPC, DOPG/DOPE 1:1 (mol/mol) and DOPG/DOPC 1:1 (mol/mol) and DOPG. The end-
points of leakage at a peptide concentration of 52 μM and a lipid concentration of 6.7 μM
are shown. Error bars indicate deviation between individual experiments (n=3).
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value for binding. For this purpose a simple binding equilibrium was
assumed where peptide interacts [P] with the membrane [M] to form
a peptide-membrane complex [PM]. This approach is equivalent to
what was described by Matos and coworkers [19]. The afﬁnity of
peptide membrane interaction can also be expressed as partitioning
coefﬁcients [20]. The relationship between the two models is
discussed in the work of Matos et al [19].
2.2. Molecular dynamics simulations
2.2.1. System set-up
Simulations were performed with BPC194 [c(KKLKKFKKLQ)], and
the linear analogue BPC193 [H-KKLKKFKKLQ-OH]. For the cyclic
peptide, a peptide bond was created between the N-terminal lysine
residue and the C-terminal glutamine residue. The initial structure of
the peptides was modelled using the leap module of AMBER 9 [21].
2.2.2. Peptide in aqueous environment
A number of systems were prepared with either one cyclic or one
linear peptide solvated by water. The cyclic peptide was initially
unstructured in all simulations but different starting conformations of
the linear analogue were tested: α-helix, bend and random-coil. An
overview of all simulations performed is shown in Table 2 (Wa-Wk),
and thedetails are presented in Table S1.All systemswere simulated in a
cubic box of length 4–5 nm and about 3000 water molecules. In a few
simulations, counterions (Cl−) were added to neutralise the system.
2.2.3. Peptide-membrane systems
Anumber of simulationswere performedwith peptides in a solvated
DPPG (1,2-dipalmitoyl-sn-glycero-3-phosphatidylglycerol) membrane
system. Simulations were performed with molar peptide:lipid (P:L)
ratios of 1:128, 2:60, 4:128 and 9:128 (and 6000–8000 water
molecules) for both BPC194 and BPC193 (see Table 2 for an overview
and Table S1 for details). Initially, the peptides were placed in thewater
phase close to the membrane surface, with distances between the
peptide and membrane ranging from 1.5 to 2.3 nm. The cyclic peptide
was initially unstructured and different conformations were tested for
the linear peptide. Multiple simulations were run from different initial
random velocity distributions for each of the P:L ratios. The simulations
were carried out in the presence and absence of counter ions, and using
different electrostatic schemes. No signiﬁcant differences were ob-
served with respect to these details of the simulations, however.
2.2.4. Simulations parameters
The GROMACS software package [22] was used to perform all MD
simulations. The GROMOS force-ﬁeld 43a2 [23] was used to describe
the peptide and peptide–solvent interactions. Simulations in water
were also run using GROMOS force-ﬁeld 53a6 [24]. The force-ﬁeld forTable 2
Overview of secondary structure and binding characteristics in all simulations performed on
present in the system, and over all independent simulations. The average binding depth as wel









Cyclic Water Wa-Wc 3 87±5 13
1:128 1Ca-1Cg 7 79±3 21
4:128 4Ca-4Cc 3 67±4 33
9:128 9Ca-9Cj 10 68±2 32
Linear Water Wd-Wk 8 84±4 16
1:128 1La-1Lb 2 100±0 0
2:60 2La-2Lb 2 – –
4:128 4La-4Lb 2 100±0 0
9:128 9La-9Lg 7 99±0 1
a Centre of mass of the peptide.
b Centre of mass of the phenyl ring of the phenylalanine residue.DPPG lipids was optimised from DPPC [25] and POPG [26] lipids,
compatible with the GROMOS96 parameters. The choline head-
groups were replaced by glycerol from the POPG force-ﬁeld, and the
tail parameters were taken from the DPPC force-ﬁeld. The parameters
were then optimised to achieve an area per lipid consistent with
experiment [27]. The equilibrated DPPG bilayer had a thickness of
3.54±0.05 nm and an area per lipid of 0.69±0.01 nm2. All force-
ﬁelds were parameterized for use with a group-based twin range cut-
off scheme (using cutoffs of 1.0/1.4 nm and a pair-list update
frequency of once per 10 steps), including a reaction ﬁeld [28,29]the cyclic (BPC194) and linear (BPC193) peptides. Results are averaged over all peptides
l as the maximum binding depth, with respect to the average position of the phosphorous
ted are calculated from the standard deviation, between all peptides in all simulations.
-
cture
Peptide deptha Phe depthb
Av. Max Av. Max
±5 – – – –
±3 −0.34±0.38 −1.16 −0.52±0.65 −1.75
±4 −0.08±0.23 −0.99 −0.03±0.29 −0.86
±2 −0.24±0.25 −1.2 −0.57±0.20 −1.4
±4 – – – –
±0 −0.18±0.25 −0.78 −0.10±0.41 −0.85
– – – –
±0 −0.10±0.18 −0.75 0.50±0.23 −0.46
±0 0.41±0.19 −0.62 0.52±0.19 −1.37
Fig. 2. Binding of cyclic and linear peptides to PG membranes. A. Time course of the
simulation 1Ca of BPC194 (pink) interacting with DPPG membranes. B. Time course of
the simulation 1Lb of BPC193 (purple). In both A and B, the head-group phosphorus
atoms are shown in yellow, the lipid tails in grey and side-chains have been removed
for clarity. C. Percentage binding of BPC418 (solid black circles) and BPC417 (solid black
squares) at 6 μM concentration to DOPG membranes assessed by ultracentrifugation
and employing the ﬂuorescence of tryptophan. Error bars denote the deviation between
individual experiments (n=4); the top X-axis: P:L ratios corresponding to lipid
concentrations indicated at the bottom axis. Dashed line: the ﬁt of the data used to
obtain the Kd.
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truncation of long-range electrostatic interactions. To test the effect
of long-range electrostatic interactions, in some simulations the RF
was replaced by the particle-mesh Ewald (PME) method. The water
was modelled using the SPC model [30]. A time step of 2 fs was used.
Bond lengths were constrained using the LINCS algorithm [31]. The
simulations were performed in the NP||PZT ensemble using periodic
boundary conditions. The temperature was weakly coupled (coupling
time 0.1 ps) to T=320 K using the Berendsen thermostat [32]. The
pressure was also weakly coupled (coupling time of 1.0 ps and
compressibility of 4.5×10−5), using a semi isotropic coupling scheme
in which the lateral (P||) and perpendicular (PZ) pressures were
coupled independently at 1 bar, corresponding to a tension-free state
of the membrane. The simulation setup is similar to that used inFig. 3. Structure of peptides in water and uponmembrane binding. Secondary structure plot i
BPC193 (B). The colours associated with the secondary structural elements are red (β-sheet
residues are shown in orange, Phe and Leu inwhite and Gln in light pink. C–E. Cyclic peptide DS
peptide DSSP plot of representative simulations at P:L ratios 1:128, 4:128 and 9:128, respective
DOPGvesicles (red line) at a P:L ratio of 0.38. J. CD spectra of the linear peptide BPC193 inbuffer,
(black, red and blue line, respectively). Peptides 0.15 mM, lipids 0.4 mM, TFE—25% (vol/vol).previous studies of peptide-membrane interactions [33,34]. For a
general review on MD studies of peptide-membrane interactions see
the work of Mátyus et al.[35].
2.2.5. Analysis
The secondary structure of the peptides was calculated with the
DSSP code [36]. For the cyclic peptide, the bonded N-terminus (K1)
and C-terminus (Q10), present in the turn region, were neglected
while calculating the secondary structure. The structural properties
were then calculated from the average number of residues involved in
each secondary structural feature along the simulation. The total “β-
structure” is reported as the sum of β-sheet and β-bridge (one
hydrogen bond less than β-sheet) and the “non-structured,” as the
sum of coil, bend and turn.
To analyse the alignment of the lysine residues, the distance
between the planes formed by the Cα, Cγ and Nζ atoms of the spatially
symmetric lysine residues K1-K8, K2-K7 and K4-K5 were calculated.
3. Results
3.1. The cyclic peptide permeabilizes the membrane and has a preference
for anionic lipids
The cyclic peptide BPC194 has a high antimicrobial activity (MIC
values ranged from 3.1 to 12 μM) and low hemolytic activity (not
exceeding 17% at 375 μM) [15]. A calcein dequenching assay was
performed to determine the membrane permeabilizing activity of the
cyclic peptide, BPC194, two cyclic analogues (BPC294 with Tyr and
BPC418 with Trp instead of Phe at position 6) and the corresponding
linear analogues BPC193, BPC293, BPC417 (see Table 1 for peptide
names and compositions). Fig. 1 summarises the results obtained for
the cyclic analogue BPC194 and shows that it caused the leakage of
calcein from vesicles comprising of anionic lipids. The leakage reached
100% in DOPG membranes though it did not exceed 5% in DOPC, even
at high P:L ratios (Fig. 1A). Experiments with liposomes composed of
mixtures of DOPG, DOPC and/or DOPE conﬁrmed that the cyclic
peptide (BPC194) has a preference for anionic lipids since the leakage
increases with the content of DOPG lipids in the vesicles (Fig. 1B). All
three cyclic analogues caused the leakage of calcein for anionic
membranes (Fig. S1), independent of the size of the vesicles (Fig. S1).
These results are line with the in vivo data [15] and are consistent with
the fact that bacterial membranes are generally more rich in
negatively charged lipids than the outer leaﬂet of the plasma
membrane of higher eukaryotes, e.g. mammalian cells [14]. The
calcein leakage from vesicles was negligible for the linear analogues,
irrespective of the lipid composition. The low antimicrobial activity of
the linear peptide is consistent with the lack ofmembrane permeation
in model membrane systems. Below, we focus on the interaction of
the cyclic and linear analogues with anionic lipids to understand the
remarkable differences in their membrane permeabilizing properties.
3.2. Both the linear and cyclic peptides bind to PG membranes
To test whether the low activity of the linear peptides stems from
their inability to bind to anionic membranes, we analysed their
membrane binding properties by MD simulations and ﬂuorescence
experiments. In theMDsimulations, the peptides (BPC193 and BPC194)
were placed in the water phase close to the surface of a DPPG bilayer at
P:L ratios of 1:128, 4:128 and 9:128. Both peptides bound to thenwater as determined by the DSSP code and representative snapshot of BPC194 (A) and
), yellow (turn), green (bend), black (β-bridge) and white (coil). In both snapshots, Lys
SP plots of the simulations at P:L ratios of 1:128, 4:128 and 9:128, respectively. F–H. Linear
ly. I. CD spectra of the cyclic BPC194 in aqueous buffer (black line) and in the presence of
in the presenceofDOPGmembranes (at P:L ratio 0.38) or a secondary structure inducer TFE
2201J.T. Mika et al. / Biochimica et Biophysica Acta 1808 (2011) 2197–2205
2202 J.T. Mika et al. / Biochimica et Biophysica Acta 1808 (2011) 2197–2205membrane rather fast and on similar (nanosecond) time scales (Fig. 2A
and B). To validate the simulation data, the ﬂuorescence of the
tryptophan in BPC417 and BPC418 was used to monitor the interaction
of the linear and cyclic peptides with the membranes. BPC417 and
BPC418 bound to DOPG membranes albeit with different afﬁnities
(Fig. 2C). BPC418 bound to themembranewith a Kd, of 7±2 μM(under
these conditions the overall P:L ratio=0.84). BPC417 bound with a Kd
for DOPGof 96±10 μM(P:L ratio=0.0625). From the data presented in
Fig. 2C, one can derive P:L ratios atwhich the amount of cyclic and linear
peptide bound is equal and compare these conditions with those in
Fig. 1A. Even at equal amounts of peptide interacting with the
membrane, the cyclic peptide is orders of magnitude more effective in
membrane permeabilization than the linear one. For instance, when the
cyclic and the linear peptide are ~60%bound (P:L ratio of around0.6 and
0.06, respectively) the cyclic peptide causes ~50% of dye leakage, while
the linear analogue is not active.
3.3. Both linear and cyclic peptides are structure-less in aqueous solution
To analyse the structure of the peptides in aqueous solution,
atomistic MD simulations aswell as CDmeasurements were performed.
In the simulations, the cyclic and the linear peptide showed no deﬁned
secondary structure in aqueous solution and appeared mainly in a non-
structured conformation (Fig. 3A and B). On average, only 13 and 16%β-
structure was adopted by the cyclic and linear peptide, respectively
(Table 2). Althoughwe found that50 ns of simulationwerenot sufﬁcient
for the peptides to completely sample their conﬁgurational space, the
simulationdata takenasawholepoints to anunstructured conformation
for both peptides in solution. The lack of secondary structure in the MD
simulations was conﬁrmed by CD measurements (Fig. 3I and J).
3.4. Cyclic peptide adopts β-structure upon binding to membranes
Upon interaction of BPC194 with the DPPG membrane surface, a
secondary structure was induced within nanoseconds in the simula-
tions (Fig. 3C–E). The average fraction of β-structure increased from
13% to 32% (Table 2). The increase inβ-structurewasmost pronounced
at the higher P:L ratios of 4:128 and 9:128. Visual inspection of theMD
simulations of BPC194 showed that the β-structure formation gives
rise to an amphipathic-like structure with a spatially symmetric
arrangement of two pairs of lysine residues: K1-K8 and K2-K7 on
opposite strands.When the peptide adopted aβ-structure, these lysine
pairs aligned in a parallelmanner and gave rise to a high charge density
(Fig. 4A and B). When the intra-strand hydrogen bonds wereFig. 4. Different binding modes of the cyclic peptide. The lysine residues are depicted in oran
In certain bindingmodes during the simulation, the lysine residues alignedwith inter-strand
and the inter-strand distances increased.weakened and the β-structure was lost, the lysine residues could
point away from each other (Fig. 4C). On average, the distances
between the lysinepairs at themembrane interfacewere reduced from
1 nm (in aqueous medium) to about 0.7 nm. Upon addition of DOPG
membranes, a substantial change in ellipticity of BPC194was observed
(Fig. 3I); similar behaviour was seen for the tryptophan (BPC418) and
tyrosine containing (BPC294) cyclic peptides but not for the linear
analogues (Fig. S3). The CD spectra of the cyclic peptides in the
presence of DOPG are reminiscent of β-sheet and β-turn structures
reported for other (cyclic) peptides [37–39]. However a quantitative
deconvolution of the spectra is difﬁcult as CD spectra simulators are
designed for large proteins rather than cyclic small peptides.
Unfortunately, it is not possible to perform solution-state NMR
measurements on the membrane-associated states of the peptides,
since the molecular mass of the vesicles to which the peptides are
associated is so large that any NMR signal of the peptide would be
broadened beyond detection.
3.5. The inactive linear peptide remains structure-less at the membrane
surface
In contrast to the cyclic peptide, the linear analogue remained fully
unstructured (Fig. 3F–H) with no intra-molecular hydrogen bonding
at the DPPG membrane interface at P:L ratios of 1:128 and 4:128
(Table 2). At the highest P:L ratios (9:128) a few intermolecular
interactionswere observed, resulting in peptide clusters. This gave rise
to someβ-sheet characteristics on the interacting peptides, originating
mainly from interactions of the peptide backbone and the glutamine
side-chain. We also performed a simulation with the linear peptide
folded into an ideal α-helix and an unfolding of the helix to random-
coil conformation was observed (Table 1; 2La-2Lb). The CD measure-
ments were entirely consistent with the MD simulations (Fig. 3J).
3.6. The cyclic and linear peptides differ in membrane penetration
BPC194 was able to penetrate deeper into the phospholipid
membrane than its linear counterpart. In the MD simulations, the
distances between the phosphorous atoms of the outer leaﬂet and the
centre of mass of the peptide were calculated and are plotted in
Fig. 5A–D. The cyclic peptide BPC194was able to insert below the level
of the phosphorus atoms (see Table 2). Although a single peptide (P:L
1:128) appeared on average to bind deeper (−0.34 nm) compared to
systems with P:L ratios of 4:128, 9:128 (−0.08 nm and −0.24 nm),
the maximum insertion for individual peptides was at P:L ratio ofge, the head-group phosphorous atoms as yellow spheres and the acyl tails in grey. A–B.
hydrogen bonds (depicted in red). C. In others, the lysines snorkelled out independently
Fig. 5. Depth of insertion of cyclic and linear peptides to PGmembranes and peptide environment changes. A–D. MD simulations of peptides. Distance between the centre of mass of
the peptides BPC193 (A) and BPC194 (B) and the phosphorus atoms of the DPPG bilayer at different P:L ratios: 1:128 (solid line), 4:128 (dashed line) and 9:128 (dotted line). At
higher P:L ratios, the distances plotted are the averages of all peptides in the system. C–D. Distance between the phenylalanine residue and head-group phosphorus atoms. The zero
value was taken as the interface boundary (horizontal solid line). E–G. Peptide environment assessed by Trp ﬂuorescence. Wavelengths of tryptophan ﬂuorescence emissionmaxima
(λmax) of BPC418 (circles, solid line) and BPC417 (squares, dashed line) in buffer (ﬁrst data point), upon addition of DOPG membranes (arrow), and following titration with NaCl up
to 350 mM. The peptide concentration was 2 μM; DOPG was added at different concentrations, yielding (E) P:L=0.0073, (F) P:L=0.071 and (G) P:L=0.88.
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large values of insertion of the cyclic peptide were associated with
high local perturbations, which led to poration of the membrane, as
discussed elsewhere [40]. The ﬂuctuations in the outer leaﬂet,
calculated as the deviation of the phosphorous atoms of the head-
groups from their centre of mass were ±0.44 nm for the cyclic
peptide. In contrast to the cyclic peptide, the linear analogue BPC193
did not embed very deep. The maximum insertion observed was
−0.62 nm below the level of the phosphorus atoms and was not
accompanied by large bilayer perturbations. Furthermore, low
perturbations were seen in comparison to the cyclic peptide and the
outer-leaﬂet ﬂuctuations were ±0.29 nm for the linear peptide.
Next, we examined the environment of the tryptophan from
ﬂuorescence emission spectra. The peptide that was initially in buffer
was exposed to DOPG vesicles, which resulted in a blue-shift of the
ﬂuorescence emission peak (λmax) of ~14 and ~10 nm for the cyclic
and linear peptides, respectively (see Fig. 5E and F; at these P:L ratios
essentially all peptides are bound). The larger blue-shift for the cyclic
peptide points to a more hydrophobic environment and thus to a
deeper insertion into the membrane. Increasing the ionic strength
resulted in a shift of theλmax of the linear peptide back towhat itwas in
the aqueousmedium,which is indicative of reversible binding. The salt
effect was not observed for the cyclic peptide, and even at the highest
P:L ratio of 0.88 (where about 50% was bound (Fig. 2C) and the
membranes were saturated with peptide), the backshift of λmax was
onlymarginal (Fig. 5G). Thus, the salt effects are also consistent with a
deeper insertion of the cyclic peptide, BPC418, as compared to the
linear one. It has been reported that certain peptides (e.g. pep-1) [41]
can translocate through the membrane without causing leakage/
poration. We believe that the shallow and reversible membrane-
embedding of BPC193 (incl. MD simulations andmuch less pronouncedﬂuorescence blue-shift of the linear peptide as compared to the cyclic
counterpart) argue against such possibility for the linear peptides.
4. Discussion
4.1. Molecular mechanism of pore formation
Based on our results, we propose here a molecular-detailed model
outlining the differences in mode of action of the cyclic and linear
peptides (schematically presented in Fig. 6). Both peptides when
present in the aqueous phase are mainly unstructured and have a
propensity to bind to (anionic) membrane surfaces. From this point
on, the behaviour of the two peptides diverges. The cyclic peptide has
a larger tendency to fold, enabling it to insert deeper into the
membrane interface. Through cooperative interactions, some of these
membrane-embedded and folded cyclic peptides cause large pertur-
bations in the bilayer. The linear peptide assumes a more extended
conformation and is unable to perturb the membrane substantially.
Finally, the cyclic peptide is able to porate the vesicles and cause dye
leakage while the linear is unable to do so. The model highlights the
structural and partitioning differences of two related peptides with
the same sequence but varying antimicrobial activity and thereby
point to the critical features required for high antimicrobial activity.
The mechanistic model proposed here resembles the one described
for gramicidin S in the sense that the cyclic peptide interacts with the
membrane, adsorbs to the bilayer surface, folds and gets inserted into
the hydrophobic core of the membrane [42]. However, for BPC194 the
poration has been conﬁrmed experimentally and evaluated with
molecular detail by MD simulations [40]. The results of our study
provide important clues for rational design of novel cyclic antimicro-
bial peptides (work in progress).
Fig. 6. A schematic view of the mechanism of action. Left: The cyclic peptide BPC194
(pink); right: the linear analogue BPC193 (purple). The ﬁve possible thermodynamic
states (stable or metastable) are: aqueous-unfolded, membrane-adsorbed, folded,
inserted and porated. The equilibrium is shifted to the right for the cyclic peptide
BPC194 and the porated state is the most favourable one. For the linear analogue
BPC193, the membrane-adsorbed is the most favoured state and the peptide remains
unfolded at the surface of the membrane.
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The cyclization of the peptides that were studied is not linked to
gain of structure in solution. However, upon membrane binding the
cyclic peptide assumes a β-structure unlike the linear one. For
BPC194, the β-structure gives rise to a spatially symmetric arrange-
ment of the lysine pairs, resulting in an amphipathic-like structure, a
conformation that was seen also for gramicidin S [43]. The linear
peptide has larger conformational entropy, and folding of the
backbone to a β-hairpin structure is less favourable than in the cyclic
peptide. The structure formation and consequently a deeper insertion
of the cyclic peptide were accompanied by local perturbations of the
membrane-leaﬂet and could be linked to its higher charge density,
compared to BPC193. The lower charge density of the linear peptide
and the formation of peptide clusters may prevent the linear peptide
from substantially perturbing or embedding into the membrane. A
correlation between high charge density and poration has been
previously seen for cyclic analogues of linear antimicrobial peptides
[44].
4.3. Folding of BPC194 is reminiscent of folding in linear β-hairpin
peptides
A very important aspect of this work is the prediction of the
peptide folded states at the membrane interface by MD simulations
and supported by CD studies. Predicting the correct folds and folding
pathways of (poly)peptides, even short ones, remains a challenge.
Folding of peptides into β-hairpins has been used as a paradigm for
protein folding and a large number of pathways such as zip-in, zip-out
and middle-out have been proposed [45–47]. Multiple, long simula-
tions and enhanced sampling methods have often been used to probe
the folding events. In contrast, in the simulations presented here,
folding at the membrane surface is sampled within nanoseconds after
the peptide binds to the membrane. While kinetics at membrane
interfaces is usually slow, the ‘fast-folding’ observed here is due to the
limited phase-space of the cyclic peptide. For BPC194, only three
hydrogen bonds are present in the folded state and due to cyclization,the backbone atoms involved in these hydrogen bonds are close
together even in the unfolded state. In water, the peptide is non-
structured because the thermal ﬂuctuations are enough to break these
three backbone hydrogen bonds that are then compensated by the
neighbouring water molecules. However, at the membrane interface
the backbone atoms (that are always spatially close) form the three
hydrogen bonds because of lack of other hydrogen-bond partners and
the lower polarity of the membrane leading to the peptide adopting
the folded state very fast. The folding is reminiscent of the zip-in
model described for linear β-hairpins, whereby the ends ﬁrst
approach each other and then the hydrogen bonds are formed.
5. Conclusions
In conclusion, there is now compelling evidence that cyclization of
certain sequences of membrane-active peptides enhances their antimi-
crobial performance. In this paper, we analyse the molecular basis for
activity in a cyclic antimicrobial peptide, BPC194 by comparing the
mechanismof action of the active and inactive analogues.We show that
the molecular basis for the enhanced activity resides most likely in the
restriction of the number of conformations in the cyclic peptide. We
show that it can adopt a favourable orientation towards the membrane
and acquire an ordered structure that allows a high charge density and
amphipathic arrangement. The latter allows the cyclic peptide to locate
itself deeper in themembraneaswell as to perturb itmore than its linear
counterpart. Thus, the alignment of lysine residues on opposite strands
leads to a high charge density and an amphipathic arrangement. We
propose that the structural and partitioning behaviour determined here
are related to the difference in poration propensity and thus the
antimicrobial activity.
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